SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: glen who wrote (99)7/18/1999 4:43:00 AM
From: Manfred Sondermann   of 250
 
>I infer that if you had done more research in addition to just
>reading the Prospectus, then you might not have even bought
>VXGN stock. Thank goodness for naivete, eh?

May be I would have bought less.

Never forget one thing: the game is not jet over!
Because this stock has a lot of hype
potential (Gates, Allen, Francis, Nobel price, conquering AIDS
after conquering the moon :) , this stock might take large jumps
in BOTH directions, up AND down. I personally am not very happy
with this high stock price right now. I would rather like to see
the price a long time below $20, so that the big investors
could buy a lot more of this stuff. This stocks better has to go
into firm hands to diminish the floating rate even more. Then,
in case of FDA approval, this stock might go up in unbelievable
highs. And in case of failure I think the stock then might fall
more disciplined.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext